子宫内膜异位症立体化管理体系(山东方案)

doi:10.6040/j.issn.1671-7554.0.2021.1009

摘要/Abstract

关键词: 子宫内膜异位症, 诊断, 治疗, 分层管理, 立体化管理

Key words: Endometriosis, Diagnosis, Treatment, Hierarchical management, Multidimensional management

中图分类号:

R711.71

山东省医师协会子宫内膜异位症和慢性盆腔痛培训基地王国云,王凯,袁明,陈子江. 子宫内膜异位症立体化管理体系(山东方案)[J]. 山东大学学报 (医学版), 2021, 59(10): 1-17.

Endometriosis and Chronic Pelvic Pain Training Center of Shandong Medical Doctor AssociationWANG Guoyun, WANG Kai, YUAN Ming, CHEN Zijiang. Multidimensional management system for endometriosis (The Program for Shandong Province)[J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 1-17.

参考文献

[1] Zondervan KT, Becker CM, Missmer SA. Endometriosis[J]. N Engl J Med, 2020, 382(13): 1244-1256.
[2] 郎景和.关于子宫内膜异位症的再认识及其意义[J].中国工程科学,2009,11(10): 137-142. LANG Jinghe. Reconsideration of endometriosis and its clinical significance [J]. Strategic Study of CAE, 2009,11(10): 137-142.
[3] 冷金花,戴毅.子宫内膜异位症治疗新观念[J]. 中华妇产科杂志, 2017, 52(7): 433-435. LENG Jinhua, DAI Yi. The new conception focusing on therapy of endometriosis [J]. Chinese Journal of Obstetrics and Gynecology, 2017, 52(7): 433-435.
[4] 中华医学会妇产科学分会子宫内膜异位症协作组. 子宫内膜异位症的诊治指南[J]. 中华妇产科杂志,2015,50(3): 161-169.
[5] National Guideline Alliance(UK). Endometriosis: diagnosis and management[M]. London: National Institute for Health and Care Excellence(UK), 2017.
[6] Zhang X, He T, Shen W. Comparison of physical examination, ultrasound techniques and magnetic resonance imaging for the diagnosis of deep infiltrating endometriosis: a systematic review and meta-analysis of diagnostic accuracy studies[J]. Exp Ther Med, 2020, 20(4): 3208-3220.
[7] Gerges B, Li W, Leonardi M, et al. Optimal imaging modality for detection of rectosigmoid deep endometriosis: systematic review and meta-analysis[J]. Ultrasound Obstet Gynecol, 2020, 58(2): 190-200.
[8] Noventa M, Scioscia M, Schincariol M, et al. Imaging modalities for diagnosis of deep pelvic endometriosis: comparison between trans-vaginal sonography, rectal endoscopy sonography and magnetic resonance imaging. A head-to-head meta-analysis[J]. Diagnostics(Basel), 2019, 9(4): 225.
[9] Nikolova T, Zivadinovic R, Evtimovska N, et al. Diagnostic performance of human epididymis protein 4 compared to a combination of biophysical and biochemical markers to differentiate ovarian endometriosis from epithelial ovarian cancer in premenopausal women[J]. J Obstet Gynaecol Res, 2017, 43(12): 1870-1879.
[10] Tuttlies F, Keckstein J, Ulrich U, et al. [ENZIAN-score, a classification of deep infiltrating endometriosis] [J]. Zentralbl Gynakol, 2005, 127(5): 275-281.
[11] Adamson GD, Pasta DJ. Endometriosis fertility index: the new, validated endometriosis staging system[J]. Fertil Steril, 2010, 94(5): 1609-1615.
[12] Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations[J]. The Lancet, 2021, 397(10276): 839-852.
[13] Brown J, Farquhar C. Endometriosis: an overview of Cochrane Reviews[J]. Cochrane Database Syst Rev, 2014, 2014(3): CD009590.
[14] Brown J, Crawford TJ, Allen C, et al. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis[J]. Cochrane Database Syst Rev, 2017, 1(1): CD004753.
[15] Abou-Setta AM, Houston B, Al-Inany HG, et al. Levonorgestrel-releasing intrauterine device(LNG-IUD)for symptomatic endometriosis following surgery[J]. Cochrane Database Syst Rev, 2013(1): CD005072. doi: 10.1002/14651858.CD005072.pub3.
[16] Katayama H, Katayama T, Uematsu K, et al. Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model[J]. Hum Reprod, 2010, 25(11): 2851-2858.
[17] Falcone T, Flyckt R. Clinical management of endometriosis[J]. Obstet Gynecol, 2018, 131(3): 557-571.
[18] Ruan X, Seeger H, Mueck AO. The pharmacology of dienogest[J]. Maturitas, 2012, 71(4): 337-344.
[19] 吴洁, 田秦杰. 复方短效口服避孕药在子宫内膜异位症治疗的应用[J]. 中国计划生育学杂志, 2011, 19(11): 702-703.
[20] 曹泽毅. 中华妇产科学[M].第3版.北京:人民卫生出版社,2014.
[21] 陈亚婷. GnRH-a联合反加疗法对子宫内膜异位症与子宫肌瘤的临床疗效研究[D]. 乌鲁木齐:新疆医科大学,2016.
[22] Kitawaki J, Kusuki I, Yamanaka K, et al. Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain[J]. Eur J Obstet Gynecol Reprod Biol, 2011, 157(2): 212-216.
[23] Marschalek J, Ott J, Husslein H, et al. The impact of GnRH agonists in patients with endometriosis on prolactin and sex hormone levels: a pilot study[J]. Eur J Obstet Gynecol Reprod Biol, 2015, 195: 156-159. doi: 10.1016/j.ejogrb.2015.10.016.
[24] 郎景和, 冷金花, 王泽华,等. 促性腺激素释放激素激动剂在子宫内膜内异症和子宫平滑肌瘤治疗中的应用专家意见[J]. 中华妇产科杂志, 2017, 52(2): 77-81. LANG Jinghe, LENG Jinhua, WANG Zehua, et al. Consensus on the complementary application of gonadotropin-releasing hormone agonist in endometriosis and uterine fibroids [J]. Chinese Journal of Obstetrics and Gynecology, 2017, 52(2): 77-81.
[25] Peng C, Huang Y, Zhou Y. Dydrogesterone in the treatment of endometriosis: evidence mapping and meta-analysis[J]. Arch Gynecol Obstet, 2021, 304(1): 231-252.
[26] Leyland N, Casper R, Laberge P, et al. Corrections to: SOGC Clinical Practice Gynaecology Committee. Endometriosis: “diagnosis and management. SOGC Clinical Practice Guideline No. 244, July 2010. J Obstet Gynaecol Can 2010, 32(Suppl): S1-S33.”[J]. J Obstet Gynaecol Can, 2010, 32(9): 825.
[27] Chapron C, Marcellin L, Borghese B, et al. Rethinking mechanisms, diagnosis and management of endometriosis[J]. Nat Rev Endocrinol, 2019, 15(11): 666-682.
[28] ETIC Endometriosis Treatment Italian Club. When more is not better: 10 'don'ts' in endometriosis management. An ETIC^* position statement [J]. Hum Reprod Open, 2019, 2019(3): hoz009.
[29] 中国医师协会妇产科医师分会子宫内膜内异症专业委员会, 中华医学会妇产科学分会子宫内膜异位症协作组. 子宫内膜异位症长期管理中国专家共识[J]. 中华妇产科杂志, 2018, 53(12): 836-841. Endometriosis Committee, Chinese Obstetricians and Gynecologists Association, Cooperative Group of Endometriosis, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Chinese consensus on the long term management of endometriosis [J]. Chinese Journal of Obstetrics and Gynecology, 2018, 53(12): 836-841.
[30] Working Group of ESGE, ESHRE, and WES,Saridogan E, Becker CM, et al. Recommendations for the surgical treatment of endometriosis. Part 1: ovarian endometrioma[J]. Hum Reprod Open, 2017, 2017(4): hox016.
[31] Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis[J]. Hum Reprod, 2014, 29(3): 400-412.
[32] Johnson NP, Hummelshoj L, World Endometriosis Society Montpellier Consortium. Consensus on current management of endometriosis[J]. Hum Reprod, 2013, 28(6): 1552-1568.
[33] Zheng Q, Mao H, Xu Y, et al. Can postoperative GnRH agonist treatment prevent endometriosis recurrence? A meta-analysis[J]. Arch Gynecol Obstet, 2016, 294(1): 201-207.
[34] Bedaiwy MA, Allaire C, Alfaraj S. Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy[J]. Fertil Steril, 2017, 107(3): 537-548.
[35] Wattanayingcharoenchai R, Rattanasiri S, Charakorn C, et al. Postoperative hormonal treatment for prevention of endometrioma recurrence after ovarian cystectomy: a systematic review and network meta-analysis[J]. BJOG, 2021, 128(1): 25-35.
[36] Brosens I, Gargett CE, Guo SW, et al. Origins and progression of adolescent endometriosis[J]. Reprod Sci, 2016, 23(10): 1282-1288.
[37] Zannoni L, Forno SD, Paradisi R, et al. Endometriosis in adolescence: practical rules for an earlier diagnosis[J]. Pediatr Ann, 2016, 45(9): e332-e335.
[38] Sauvan M, Chabbert-Buffet N, Geoffron S, et al. [Management of painful endometriosis in adolescents: CNGOF-HAS Endometriosis Guidelines] [J]. Gynecol Obstet Fertil Senol, 2018, 46(3): 264-266.
[39] Stuparich MA, Donnellan NM, Sanfilippo JS. Endometriosis in the adolescent patient[J]. Semin Reprod Med, 2017, 35(1): 102-109.
[40] Seo JW, Lee DY, Yoon BK, et al. The efficacy of postoperative cyclic oral contraceptives after gonadotropin-releasing hormone agonist therapy to prevent endometrioma recurrence in adolescents[J]. J Pediatr Adolesc Gynecol, 2017, 30(2): 223-227.
[41] Staal AH, Van Der Zanden M, Nap AW. Diagnostic delay of endometriosis in the Netherlands[J]. Gynecol Obstet Invest, 2016, 81(4): 321-324.
[42] Roman H, Moatassim-Drissa S, Marty N, et al. Rectal shaving for deep endometriosis infiltrating the rectum: a 5-year continuous retrospective series[J]. Fertil Steril, 2016, 106(6): 1438-1445.e2.
[43] Darwish B, Roman H. Surgical treatment of deep infiltrating rectal endometriosis: in favor of less aggressive surgery[J]. Am J Obstet Gynecol, 2016, 215(2): 195-200.
[44] Nezhat C, Li A, Falik R, et al. Bowel endometriosis: diagnosis and management[J]. Am J Obstet Gynecol, 2018, 218(6): 549-562.
[45] Koga K, Takamura M, Fujii T, et al. Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis[J]. Fertil Steril, 2015, 104(4): 793-801.
[46] Muzii L, Di Tucci C, Achilli C, et al. Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis[J]. Am J Obstet Gynecol, 2016, 214(2): 203-211.
[47] Johnson NP, Hummelshoj L, Adamson GD, et al. World Endometriosis Society consensus on the classification of endometriosis[J]. Hum Reprod, 2017, 32(2): 315-324.
[48] Tomassetti C, Geysenbergh B, Meuleman C, et al. External validation of the endometriosis fertility index(EFI)staging system for predicting non-ART pregnancy after endometriosis surgery[J]. Hum Reprod, 2013, 28(5): 1280-1288.
[49] Gemmell LC, Webster KE, Kirtley S, et al. The management of menopause in women with a history of endometriosis: a systematic review[J]. Hum Reprod Update, 2017, 23(4): 481-500.
[50] Matias-Guiu X, Stewart CJR. Endometriosis-associated ovarian neoplasia[J]. Pathology, 2018, 50(2): 190-204.
[51] Anglesio MS, Yong PJ. Endometriosis-associated ovarian cancers[J]. Clin Obstet Gynecol, 2017, 60(4): 711-727.
[52] 杨波, 谭俊杰, 王攀,等. 项目管理模式在医院多学科协作诊疗中的应用实践[J]. 西南军医,2017,19(6):588-589.
[53] Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: a committee opinion[J]. Fertil Steril, 2014, 101(4): 927-935.
[54] Kvaskoff M, Horne AW, Missmer SA. Informing women with endometriosis about ovarian cancer risk[J]. Lancet, 2017, 390(10111): 2433-2434.
[55] Gambadauro P, Carli V, Hadlaczky G. Depressive symptoms among women with endometriosis: a systematic review and meta-analysis[J]. Am J Obstet Gynecol, 2019, 220(3): 230-241.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed